Table 3.
Characteristics | LNM-positive (n = 60) | LNM-negative (n = 45) | p-value |
---|---|---|---|
ctEMVI status | <0.001 | ||
Positive | 49 (81.7) | 12 (26.7) | |
Negative | 11 (18.3) | 33 (73.3) | |
ctN status | <0.001 | ||
Positive | 42 (70.0) | 13 (28.9) | |
Negative | 18 (30.0) | 32 (71.1) | |
Tumor location | 0.507 | ||
Cardia | 13 (21.7) | 11 (24.4) | |
Body | 21 (35.0) | 11 (24.4) | |
Antrum | 26 (43.3) | 23 (51.1) | |
Morphology | 0.213 | ||
Focal | 50 (83.3) | 33 (73.3) | |
Diffuse | 10 (16.7) | 12 (26.7) | |
Tumor margin | 0.054 | ||
Well-defined margin | 33 (55.0) | 33 (73.3) | |
Poorly defined margin | 27 (45.0) | 12 (26.7) | |
Tumor volume, mL | 40.77 ± 31.86 | 22.09 ± 17.03 | <0.001 |
Degree of enhancement | |||
Arterial phase | 0.023 | ||
Low | 13 (21.7) | 21 (46.7) | |
Moderate | 21 (35.0) | 12 (26.7) | |
High | 26 (43.3) | 12 (26.7) | |
Venous phase | 0.048 | ||
Low | 8 (13.3) | 15 (33.3) | |
Moderate | 16 (26.7) | 10 (22.2) | |
High | 36 (60.0) | 20 (44.4) | |
Dynamic enhancement pattern | 0.455 | ||
Persistently low enhancement | 18 (30.0) | 20 (44.4) | |
Progressively enhanced pattern | 22 (36.7) | 13 (28.9) | |
Gradually attenuated pattern | 2 (3.3) | 2 (4.4) | |
Persistently high enhancement | 18 (30.0) | 10 (22.2) |
LNM, lymph node metastasis; ctEMVI, CT-detected extramural venous invasion.
Data in parentheses are percentages.